Erratum to: Chordoma: The Quest for Better Treatment Options

Por Heery, Christopher R.
Publicado no Oncol Ther (2016)

Chordoma: The Quest for Better Treatment Options

Por Heery, Christopher R.
Publicado no Oncol Ther (2016)

Immunotherapy in prostate cancer: emerging strategies against a formidable foe

Por Bilusic, Marijo, Heery, Christopher, Madan, Ravi A.
Publicado em 2011

Combination of vaccine and immune checkpoint inhibitor is safe with encouraging clinical activity

Por Madan, Ravi A, Heery, Christopher R., Gulley, James L.
Publicado em 2012

Poxviral-based vaccine elicits immunologic responses in prostate cancer patients

Por Madan, Ravi A, Heery, Christopher R, Gulley, James L
Publicado em 2014

Therapeutic Cancer Vaccines in Prostate Cancer: The Quest for Intermediate Markers of Response

Por Kim, Joseph W., Bilusic, Marijo, Heery, Christopher J., Madan, Ravi A.
Publicado em 2012

Clinical Evaluation of TRICOM Vector Therapeutic Cancer Vaccines

Por Madan, Ravi A., Bilusic, Marijo, Heery, Christopher, Schlom, Jeffrey, Gulley, James L.
Publicado em 2012

NUCLEAR BRACHYURY EXPRESSION IS CONSISTENT IN CHORDOMA, COMMON IN GERM CELL TUMORS AND SMALL CELL CARCINOMAS AND RARE IN OTHER CARCINOMAS AND SARCOMAS. AN IMMUNOHISTOCHEMICAL STUDY...

Por Miettinen, Markku, Wang, Zengfeng, Lasota, Jerzy, Heery, Christopher, Schlom, Jeffrey, Palena, Claudia
Publicado no Am J Surg Pathol (2015)

Nivolumab, anti-programmed death-1 (PD-1) monoclonal antibody immunotherapy: Role in advanced cancers

Por Rajan, Arun, Kim, Chul, Heery, Christopher R., Guha, Udayan, Gulley, James L.
Publicado no Hum Vaccin Immunother (2016)

Exploiting Synergy: Immune-Based Combinations in the Treatment of Prostate Cancer

Por Burotto, Mauricio, Singh, Nishith, Heery, Christopher R., Gulley, James L., Madan, Ravi A.
Publicado no Front Oncol (2014)

Resources Required for Semi-Automatic Volumetric Measurements in Metastatic Chordoma: Is Potentially Improved Tumor Burden Assessment Worth the Time Burden?

Por Fenerty, Kathleen E., Patronas, Nicholas J., Heery, Christopher R., Gulley, James L., Folio, Les R.
Publicado no J Digit Imaging (2015)

Flow-cytometry phenotypic assessment of immune cell subsets reflecting function for the identification of breast cancer patients receiving vaccine plus docetaxel with longer progre...

Por Grenga, Italia, Donahue, Renee N, Gulley, James L, Heery, Christopher, Madan, Ravi A, Schlom, Jeffrey, Farsaci, Benedetto
Publicado em 2013

Antibody-dependent cellular cytotoxicity (ADCC) activity of a novel anti-PD-L1 antibody avelumab (MSB0010718C) on human tumor cells

Por Boyerinas, Benjamin, Jochems, Caroline, Fantini, Massimo, Heery, Christopher R., Gulley, James L., Tsang, Kwong Yok, Schlom, Jeffrey
Publicado no Cancer Immunol Res (2015)

Impact of age on antigen-specific T lymphocyte response in patients treated with PSA-TRICOM

Por Singh, Harpreet, Madan, Ravi, Marte, Jennifer, O'Sullivan-Coyne, Geraldine, Steinberg, Seth, Heery, Christopher, Schlom, Jeffrey, Gulley, James
Publicado no J Immunother Cancer (2014)

Predicting clinical outcomes in chordoma patients receiving immunotherapy: a comparison between volumetric segmentation and RECIST

Por Fenerty, Kathleen E., Folio, Les R., Patronas, Nicholas J., Marté, Jennifer L., Gulley, James L., Heery, Christopher R.
Publicado no BMC Cancer (2016)

Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab

Por Fujii, Rika, Friedman, Eitan R., Richards, Jacob, Tsang, Kwong Y., Heery, Christopher R., Schlom, Jeffrey, Hodge, James W.
Publicado no Oncotarget (2016)

Investigation of antibody dependent cellular cytotoxicity as a mechanism of action for a novel anti-PD-L1 monoclonal antibody

Por Boyerinas, Benjamin, Jochems, Caroline, Hance, Kenneth W, Heery, Christopher R, Gulley, James L, Sabzevari, Helen, Schlom, Jeffrey, Tsang, Kwong
Publicado no J Immunother Cancer (2014)

Digital immunohistochemistry analysis of intratumoral immune infiltrates in prostate cancer patients treated with intraprostatic/systemic PSA-TRICOM vaccine

Por Farsaci, Benedetto, Jochems, Caroline, Grenga, Italia, Donahue, Renee N, Gulley, James L, Heery, Christopher R, Madan, Ravi A, Schlom, Jeffrey
Publicado em 2013

PD-1 and PD-L1 expression on PBMC subsets in normal individuals and cancer patients

Por Lepone, Lauren, Donahue, Renee N, Grenga, Italia, Gulley, James L, Heery, Christopher R, Madan, Ravi A, Schlom, Jeffrey, Farsaci, Benedetto
Publicado no J Immunother Cancer (2014)

Effect of age and cancer on peripheral immune cell subsets and their PD-1 and PD-L1 expression

Por Grenga, Italia, Lepone, Lauren, Donahue, Renee, Richards, Jacob, Metenou, Simon, Heery, Christopher R, Madan, Ravi, Gulley, James L, Schlom, Jeffrey
Publicado no J Immunother Cancer (2015)